Protective effect of Nocardia opaca lysozyme digest in experimental murine Candida albicans infections

Medical Mycology

Volumn 39, Issue 2, 2001, Pages 221-227

  Ivanovska, N ^a  

^a Bulgarian Accademy of Sciences   (Bulgaria)

Author keywords

Candida albicans; Immunosuppression; Nocardia lysozyme digest

Indexed keywords

COBROTOXIN; COMPLEMENT COMPONENT C5; CYCLOPHOSPHAMIDE; LYSOZYME; NOCARDIA OPACA LYSOZYME DIGEST; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG EFFECT; EXPERIMENTAL INFECTION; FEMALE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; LYMPH NODE; MOUSE; MOUSE STRAIN; MYCOSIS; NOCARDIA; NONHUMAN; PROTECTION; RHODOCOCCUS; SPLEEN CELL; SURVIVAL; YEAST CELL;

EID: 0035033484     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.2.221.227     Document Type: Article

References (27)

1. Odds FC, Candida and Candidosis. Leicester: Leicester University Press, 1979: 205-307.
2. Kirkpatrick CH, Host factors in defense against fungal infections. Am J Med 1984; 77: 1-12.
3. Moser SA, Domer JE, Effects of cyclophosphamide on murine candidiasis. Infect Immun 1980; 27: 376-386.
4. Pearsall NN, Adams BL, Bunni R, Immunologie responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol 1978; 120: 1176-1180.
5. Fidel JPL, Sobel JD, The role of cell-mediated immunity in candidiasis. Trends Microbiol 1994; 6: 202-206.
6. Romani L, Cenci E, Mencacci A, et al, Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun 1992; 60: 4950-4952.
7. Puccetti P, Romani L, Bistoni F, A THl-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3: 237-240.
8. Romani L, Puccetti P, Bistoni F, Biological role of helper T-cell subsets in candidiasis. Chem Immunol 1996; 63: 113-137.
9. Murphy JW, Bistoni F, Deepe GS, et al, Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol 1998; 36: 109-118.
10. Mencacci A, Cenci E, Bistoni F, et al, Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. Res Immunol 1998; 48: 352-361.
11. Hector RF, Domer JE, Carrow EW, Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38: 1020-1028.
12. Ashman RB, Bolitho EM, Papadimitriou JM, Patterns of resistance to Candida albicans in inbred mouse strains. Immunol Cell Biol 1993; 71: 221-225.
13. Fulurija A, Ashman RB, Papadimitriou JM, Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice. FEMS Immunol Med Microbiol 1996; 14: 83-94.
14. Parant M, Influence of synthetic adjuvants on nonspecific resistance to infections. Int J Immunopharmac 1994; 16: 445449.
15. Barot-Ciorbaru R, Immunomodulation by bacterial fractions. Int J Immunopharmac 1994; 16: 469-473.
16. Ivanovska N, Georgieva P, Barot-Ciorbaru R, Correlation between inhibited alternative complement activity and the protective effect induced by Nocardia lysozyme digest (NLD) during Klebsiella pneumoniae infection in mice. Int J Immunopharmac 1996; 18: 515-519.
17. Georgieva P, Ivanovska N, Barot-Ciorbaru R, Immunomodulatory properties of Nocardia lysozyme digest (NLD) in complement normal and C5-deficient mice. Vaccine 1998; 16: 12371242.
18. Ciorbaru R, Adam AJ, Petit J, Lederer E, Bona C, Chedid L. Isolation of mitogenic and adjuvant fractions from various species of Nocardia. Infect Immun 1975; 11: 257-264.
19. Barot-Ciorbaru R, Brochier J, Miyawaki T, et al, Stimulation of human B-lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure activity relationship. ./ Immunol 1985; 135: 3277-3283.
20. Ivanovska N, Neychev H, Georgieva P, Barot-Ciorbaru R, Modulation of complement activity by Nocardia lysozyme digest (NLD). Int J Immunopath Pharmacol 1996; 9: 113-117.
21. Leibovici J, Hoenig S, Horodniceanu E, Barot-Ciorbaru R, Local cellular host response induced by Nocardia-delipidated cell mitogen in lewis lung carcinoma-bearing mice. In vivo 1990; 4: 299-308.
22. Leibovici J, Hoenig S, Pinchassov A, Barot-Ciorbaru R. Macrophage involvement in the antitumoral effect of Nocard/fl-delipidated cell mitogen (NDCM). In vivo 1991: 5: 365-374.
23. Mosmann TR, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J Immunol Meth 1983: 65: 55-63.
24. Kagaya KT, Shinoda T, Fukazawa Y, Murine defense mechanism against Candida albicans infection. I. Collaboration of cellmediated and humoral immunities in protection against systemic C. albicans infection. Microbiol Immunol 1981; 25: 647-654.
25. Rivas V, Rogers TJ, Studies on the cellular nature of Candida albicans-induced suppression. J Immunol 1983; 130: 376-379.
26. Ashman RB, Murine candidiasis: cell mediated immune responses correlate directly with susceptibility and resistance to infection. Immunol Cell Biol 1990; 68: 15-20.
27. Hutrel B, Lagrange PH, Michel J-C. Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice. Infect Immun 1981:31: 95-101.